RESUMEN
The bacteriologic and clinical effects of early antibiotic treatment of Campylobacter jejuni enteritis were studied. Erythromycin rapidly eliminated C. jejuni from stools, whereas trimethoprim-sulfamethoxazole did not. Despite its bacteriologic effectiveness, erythromycin did not reduce the duration or severity of diarrhea, abdominal pain, or other symptoms.
Asunto(s)
Infecciones por Campylobacter/tratamiento farmacológico , Enteritis/tratamiento farmacológico , Eritromicina/uso terapéutico , Sulfametoxazol/uso terapéutico , Trimetoprim/uso terapéutico , Adulto , Infecciones por Campylobacter/microbiología , Campylobacter fetus/efectos de los fármacos , Niño , Combinación de Medicamentos/farmacología , Combinación de Medicamentos/uso terapéutico , Enteritis/microbiología , Eritromicina/farmacología , Heces/microbiología , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Sulfametoxazol/farmacología , Factores de Tiempo , Trimetoprim/farmacología , Combinación Trimetoprim y SulfametoxazolRESUMEN
Milk specimens, 75 from cows immunized against cholera toxin and 35 from a human population in which enterotoxigenic Escherichia coli and rotaviral infections are endemic, were collected as paired filter paper and frozen whole milk samples. Each pair was tested for antibody activity against heat-labile E. coli and Vibrio cholerae enterotoxins. Additionally, 12 of the 35 paired human milk samples stored as frozen whole milk and dried on filter paper were tested for anti-rotavirus immunoglobulin A. Anti-enterotoxin and anti-rotavirus immunoglobulin A titers in milk dried on filter paper compared favorably with those of their frozen whole milk pairs. Filter paper samples offered considerable advantages for field collection, transportation, and storage over frozen liquid samples.